Overland Park, KANSAS1 Active Studies

Spinal Muscular Atrophy Clinical Trials in Overland Park, KANSAS

Find 1 actively recruiting spinal muscular atrophy clinical trials in Overland Park, KANSAS. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
50
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Overland Park

About Spinal Muscular Atrophy Clinical Trials in Overland Park

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 1 spinal muscular atrophy clinical trials recruiting participants in Overland Park, KANSAS. These studies are seeking a combined 50 participants. Research is being sponsored by University of Kansas Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Overland Park — FAQ

Are there spinal muscular atrophy clinical trials in Overland Park?

Yes, there are 1 spinal muscular atrophy clinical trials currently recruiting in Overland Park, KANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Overland Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Overland Park research site will contact you about next steps.

Are clinical trials in Overland Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Overland Park studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 1 active trials in Overland Park are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov